https://www.ajmc.com/view/ngs-based-assay-shows-feasibility-potential-cost-savings-in-newborn-sma-screening
Investigators note that although the overall cost for implementing next-generation sequencing (NGS) testing would be more than implementing current polymerase chain reaction (PCR)–based testing, the assay may be more cost effective overall because it screens …
Create an account or login to join the discussion